These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10713690)

  • 1. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.
    Deng CX; Scott F
    Oncogene; 2000 Feb; 19(8):1059-64. PubMed ID: 10713690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
    Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L; Wynshaw-Boris A; Deng CX
    Nat Genet; 1999 May; 22(1):37-43. PubMed ID: 10319859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
    Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
    Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.
    Moynahan ME
    Oncogene; 2002 Dec; 21(58):8994-9007. PubMed ID: 12483515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammary tumor formation in p53- and BRCA1-deficient mice.
    Cressman VL; Backlund DC; Hicks EM; Gowen LC; Godfrey V; Koller BH
    Cell Growth Differ; 1999 Jan; 10(1):1-10. PubMed ID: 9950212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of BRCA1 and its interacting proteins.
    Deng CX; Brodie SG
    Bioessays; 2000 Aug; 22(8):728-37. PubMed ID: 10918303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral transduction of splice variant Brca1-Delta11 or mutant Brca1-W1777Stop causes mouse epithelial mammary atypical duct hyperplasia.
    Bachelier R; Vincent A; Mathevet P; Magdinier F; Lenoir GM; Frappart L
    Virchows Arch; 2002 Mar; 440(3):261-6. PubMed ID: 11889595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.
    Jerry DJ; Kittrell FS; Kuperwasser C; Laucirica R; Dickinson ES; Bonilla PJ; Butel JS; Medina D
    Oncogene; 2000 Feb; 19(8):1052-8. PubMed ID: 10713689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
    Randrianarison V; Marot D; Foray N; Cabannes J; Méret V; Connault E; Vitrat N; Opolon P; Perricaudet M; Feunteun J
    Cancer Gene Ther; 2001 Oct; 8(10):759-70. PubMed ID: 11687899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice.
    Deng CX
    Mutat Res; 2001 Jun; 477(1-2):183-9. PubMed ID: 11376699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.
    Bowen TJ; Yakushiji H; Montagna C; Jain S; Ried T; Wynshaw-Boris A
    Cancer Res; 2005 Oct; 65(19):8736-46. PubMed ID: 16204043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability.
    Shen SX; Weaver Z; Xu X; Li C; Weinstein M; Chen L; Guan XY; Ried T; Deng CX
    Oncogene; 1998 Dec; 17(24):3115-24. PubMed ID: 9872327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.
    Brodie SG; Xu X; Qiao W; Li WM; Cao L; Deng CX
    Oncogene; 2001 Nov; 20(51):7514-23. PubMed ID: 11709723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for BRCA1 communication with the inactive X chromosome.
    Silver DP; Dimitrov SD; Feunteun J; Gelman R; Drapkin R; Lu SD; Shestakova E; Velmurugan S; Denunzio N; Dragomir S; Mar J; Liu X; Rottenberg S; Jonkers J; Ganesan S; Livingston DM
    Cell; 2007 Mar; 128(5):991-1002. PubMed ID: 17350581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
    Robinson GW; Wagner KU; Hennighausen L
    Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
    DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
    Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 gene in breast cancer.
    Rosen EM; Fan S; Pestell RG; Goldberg ID
    J Cell Physiol; 2003 Jul; 196(1):19-41. PubMed ID: 12767038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
    Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
    Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.